纳斯达克 · USD

Aspire Biopharma Holdings, Inc. (ASBPW) 股票分析

Aspire Biopharma Holdings, Inc.（ASBPW）是在纳斯达克上市的股票，以美元交易。

ASBPW

$0.02

$0.00 (0.00%)

2026年9月1日 · 收盘

这是一只衍生品——Aspire Biopharma Holdings, Inc.（ASBP）普通股的认股权证。

发行人的基本面数据显示在发行人页面，而非本页。

查看ASBP →

价格走势

悬停查看每日收盘价。虚线表示区间起始价。

ASBPW 关键统计数据

数据截至2026年9月1日

交易

开盘价: $0.04
前收盘价: $0.02
当日波动区间: 0.02–0.02
52周波动区间: 0.02–0.02
成交量: 100
Beta系数: 0.17

仅显示公司披露的指标。数据由Yahoo Finance通过yfinance提供。每日更新。

ASBPW 历年回报率

历年回报率根据每日收盘价计算。不完整年度以浅色显示并标有星号。

年份	回报率
2026 (不完整年度)	−50.00%
2025 (不完整年度)	+0.00%

数据截至2026年9月1日。

关于Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

公司简介以英文显示。

访问官网 →